Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spooner, J. W.
Right arrow Articles by Baloh, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spooner, J. W.
Right arrow Articles by Baloh, R. W.
NEUROLOGY 1979;29:29
© 1979 American Academy of Neurology

Eye movement fatigue in myasthenia gravis

Joseph W. Spooner, M.D. and Robert W. Baloh, M.D.

Department of Neurology (Dr. Spooner), and the Reed Neurological Research Center, Department of Neurology (Dr. Baloh), UCLA School of Medicine, Los Angeles, California.

An 18-year-old woman presented with dissociated nystagmus that was first attributed to multiple sclerosis. When she attempted to maintain 30-degree horizontal gaze deviation in either direction, there was progressive weakness of the adducting eye and increasing amplitude of nystagmus in the abducting eye. The amplitude and maximum velocity of repetitive one-per-second 30-degree saccades progressively decreased over a 3-minute period. Intravenous edrophonium completely abolished the dissociated nystagmus and adducting muscle weakness, and returned the saccade maximum velocity to normal. Her subsequent response to pyridostigmine and thymectomy confirmed the diagnosis of myasthenia gravis.

Reprint requests should be addressed to Dr. Baloh, Department of Neurology, Reed Neurological Research Center, Center for the Health Sciences, UCLA, Los Angeles, CA 90024.

This study was supported by NIH Grant NS 09823.

Accepted for publication November 14, 1977.




This article has been cited by other articles:


Home page
IOVSHome page
H. Yin, J. S. Stahl, F. H. Andrade, C. A. McMullen, S. Webb-Wood, N. J. Newman, V. Biousse, D. C. Wallace, and M. T. Pardue
Eliminating the Ant1 Isoform Produces a Mouse with CPEO Pathology but Normal Ocular Motility
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4555 - 4562.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by AAN Enterprises, Inc.